stroke - Nursing Case Study
Pathophysiology
• Primary mechanism: Ischemic stroke occurs when a blood clot obstructs an artery supplying the brain, leading to reduced oxygen and nutrient delivery, causing cellular death and loss of neurological function.
• Secondary mechanism: Hemorrhagic stroke results from the rupture of a blood vessel, causing bleeding in or around the brain, leading to increased intracranial pressure and subsequent brain tissue damage.
• Key complication: Both types of stroke can result in neuronal injury and edema, leading to deficits such as paralysis, speech difficulties, or cognitive impairments, significantly impacting patient recovery and quality of life.
Patient Profile
Demographics:
67-year-old male, retired construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia
• Current medications: Lisinopril, Metformin, Atorvastatin, Aspirin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Sudden onset of weakness on the right side of the body
• Key symptoms: Slurred speech, facial droop on the right, difficulty walking, confusion
• Vital signs: Blood pressure 190/110 mmHg, heart rate 102 bpm, respiratory rate 22 breaths per minute, temperature 37.8°C, oxygen saturation 91% on room air
Section 1
New Complications:
As the healthcare team continues to manage the 67-year-old male patient who presented with an ischemic stroke, new complications have emerged. Despite initial interventions aimed at stabilizing his condition, the patient developed signs of increased intracranial pressure (ICP). Clinically, this is evidenced by a sudden worsening of his neurological status. The patient, previously responsive to verbal stimuli, now exhibits diminished responsiveness, with a marked decrease in his Glasgow Coma Scale (GCS) score from 13 to 9. Additionally, his pupils are noted to be unequal, with the right pupil sluggishly reactive to light compared to the left.
These changes prompt the care team to consider the possibility of hemorrhagic transformation, a known complication in ischemic strokes, especially given his uncontrolled hypertension. A stat CT scan of the head is ordered, revealing a small hemorrhage at the site of the initial ischemic event. This finding indicates a conversion from an ischemic to a hemorrhagic stroke, necessitating a shift in the treatment approach to focus on managing the bleeding and controlling the ICP.
The patient's vital signs also reflect these changes, with a continued elevated blood pressure of 200/115 mmHg despite antihypertensive therapy, suggesting poor control of the underlying hypertension. The increased ICP may be contributing to this elevation. The nursing team, in collaboration with the physician, initiates an intravenous infusion of mannitol to reduce cerebral edema and the elevated ICP. Furthermore, a continuous infusion of labetalol is started to achieve better blood pressure control. The team closely monitors the patient's neurological status, vital signs, and laboratory values, such as blood glucose levels, to prevent further complications. This new development challenges the team to adapt the care plan dynamically, reflecting the interconnected nature of the patient's complex pathophysiology.
Section 2
As the treatment progresses, the healthcare team continues to closely monitor the patient's response to the interventions aimed at managing the increased ICP and hemorrhagic transformation. Over the next 24 hours, the nursing team observes mixed responses to the ongoing therapies. While the infusion of mannitol appears to stabilize the patient's neurological status momentarily, with the GCS score improving slightly to 10, the patient's blood pressure remains significantly elevated, fluctuating between 190/110 mmHg and 200/115 mmHg. This persistent hypertension raises concerns about the potential for further exacerbation of the hemorrhage or additional ischemic events.
In the context of these developments, the team orders repeat imaging and additional laboratory tests to reassess the patient's condition. The follow-up CT scan reveals a slight increase in the size of the hemorrhage, indicating that the current interventions have not fully mitigated the risk of expansion. Laboratory results show an elevated serum creatinine level of 1.8 mg/dL, suggesting possible renal impairment, likely secondary to the aggressive use of mannitol and labetalol. This finding necessitates a careful reassessment of the fluid management and antihypertensive strategy to prevent further renal compromise while continuing to address the elevated ICP and blood pressure.
These new complications require the care team to refine their clinical reasoning and adapt the treatment plan accordingly. The nephrology and neurology teams are consulted to provide specialized insights into optimizing the patient's care. Adjustments to the medication regimen, including potential alternative antihypertensives with renal protective properties, are considered. The dynamic interplay of the patient’s neurological status, blood pressure control, and renal function underscores the complexity of managing such cases, challenging the healthcare team to maintain a delicate balance in the patient's evolving clinical picture.
Section 3
As the healthcare team continues to monitor the patient, a change in status becomes apparent. Over the next few hours, the patient's neurological condition begins to deteriorate again. The Glasgow Coma Scale (GCS) score drops to 8, indicating a significant decline in consciousness. This alarming change prompts an urgent reassessment of the patient's overall status and necessitates immediate action to prevent further neurological compromise. The nursing staff notes that despite the ongoing mannitol infusion, the patient exhibits signs of increased intracranial pressure, such as pupil dilation and a sluggish response to light on the right side, coupled with irregular, labored breathing patterns.
In response to these developments, the team decides to adjust the treatment approach. Mannitol administration is reevaluated, particularly in light of the elevated serum creatinine level, which indicates that renal function is being impacted by the osmotic diuretic's effects. The nephrology team suggests an alternative strategy, recommending the cautious introduction of hypertonic saline to manage ICP while potentially offering a more favorable profile for renal function. Simultaneously, the neurology team advises on initiating an intravenous infusion of nicardipine, a calcium channel blocker, to better control the patient's hypertension without further compromising renal function.
These adjustments reflect the team's commitment to dynamic clinical reasoning, carefully balancing the interconnected issues of intracranial pressure, blood pressure management, and renal function. The updated interventions aim to stabilize the patient's condition, but the team remains vigilant for any new complications that may arise, prepared to modify the treatment plan as necessary. The patient's evolving clinical picture underscores the importance of collaborative care and the need for constant reevaluation to optimize outcomes in complex stroke management.
Section 4
With the revised treatment plan in place, the healthcare team closely monitors the patient's response to the interventions. Over the next few hours, a positive response to the hypertonic saline infusion begins to emerge. The patient's neurological status shows subtle improvement, with the Glasgow Coma Scale (GCS) score inching up to 10. The team notes a slight reduction in pupil dilation, and the pupillary response to light on the right side becomes more brisk, suggesting a decrease in intracranial pressure. Additionally, the patient's breathing pattern stabilizes, exhibiting more regular and less labored respirations.
Vital signs are carefully assessed to ensure the stability of the patient's condition. Blood pressure readings stabilize at 140/85 mmHg, a desirable target given the introduction of nicardipine. Furthermore, a repeat serum creatinine test reveals a slight decrease to 1.6 mg/dL, indicating an improvement in renal function, likely due to the cessation of mannitol and the tailored use of hypertonic saline. Despite these encouraging signs, the team remains vigilant, aware that the situation can change rapidly.
The collaborative approach between the neurology, nephrology, and nursing teams continues to be crucial. They prepare for potential new complications, such as cerebral edema or further renal impairment, which could alter the patient's clinical trajectory. The team emphasizes the importance of continuous monitoring of neurological status, renal function, and vital signs to promptly identify and address any additional complications. This vigilant strategy is essential to navigating the complexities of the patient's recovery journey while optimizing outcomes in the context of stroke management.
Section 5
As the patient stabilizes, the healthcare team remains vigilant for any new complications that may arise. Approximately 12 hours into the revised treatment plan, the patient's condition takes an unexpected turn. The nursing team notes an increase in blood pressure to 165/95 mmHg, and the patient becomes slightly more agitated, showing signs of increased restlessness. Neurological assessments indicate that the GCS has slightly decreased back to 9, with the patient now demonstrating a sluggish pupillary response on the left side, suggesting possible fluctuations in intracranial pressure.
Concurrently, the nursing staff observes a change in the patient's urine output, which has decreased significantly over the past few hours. A repeat serum creatinine test reveals a rise to 2.0 mg/dL, raising concerns about potential acute kidney injury. The nephrology team is consulted immediately to evaluate the need for adjustments in fluid management and potential interventions to support renal function.
The interdisciplinary team convenes to discuss these developments, acknowledging the interplay between cerebral and renal dynamics in this complex case. They deliberate on the potential causes of the blood pressure elevation and decreased urine output, considering factors such as fluid shifts, medication effects, and the need for additional imaging or laboratory tests. The team decides to adjust the patient's nicardipine dosage and consider the use of additional diuretics under careful monitoring. The collaborative effort continues to be crucial in addressing these challenges, with a focus on maintaining a delicate balance between managing intracranial pressure and preserving renal function.